Blue Light, EMF, Circadian Rhythm, Mitochondria and Quantum Biology for IBD: Jack Kruse, MD
1h 20m
·
Against the Grain
·
Dr. Jack Kruse is a practicing neurosurgeon and also a "theoretical quantum biologist." He specifically has an interest in our light environment, circadian rhythm and mitochondria in relation to health and disease.
In my opinion, these are topics that require more attention and research in the context of Crohn’s disease and ulcerative colitis.
This is one of the most high level podcasts I have ever recorded as Dr. Kruse’s knowledge base regarding these topics is unparalleled.
You will hear things in this interview that will make you rethink some of your assumptions about what you think you know about how the human body works. We overall need to do this more often for there to be progress in the treatment of IBD.
Resist the temptation to immediately believe or disbelieve anything that we discussed but actually go into the literature. See for yourself if Dr. Kruse is right. I did this myself on some of these topics..
As a disclaimer, nothing in this podcast should be interpreted as medical advice from my perspective. None of these interventions have been investigated in the context of clinical trials to determine if they affect actual clinical outcomes in IBD. Also increasing sun exposure with IBD, especially while on certain immunosuppressive medications and biologics, comes with the controversial but theoretical risk of skin cancer.
Dr. Kruse's website: https://jackkruse.com
Some referenced mentioned in podcast:
Sun exposure associated with decreased mortality
https://www.ncbi.nlm.nih.gov/pubmed/26992108
Red light therapy as a drug equivalent
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643261/
Cell phone radiation and cancer (NTP study)
https://ntp.niehs.nih.gov/results/areas/cellphones/
EMF as Risk for Disease
https://www.sciencedirect.com/science/article/pii/S0306987719300040
The episode Blue Light, EMF, Circadian Rhythm, Mitochondria and Quantum Biology for IBD: Jack Kruse, MD from the podcast Against the Grain has a duration of
1:20:57. It was first published
More episodes from Against the Grain
Episode 34: My Unbiased Breakdown of Zeposia (Ozanimod) for Ulcerative Colitis
This is my review of Zeposia (Ozanimod), a new once a day oral medication for moderate to severe ulcerative colitis. I go over the True North Study (https://www.nejm.org/doi/full/10.1056/NEJMoa2033617) in detail including efficacy and safety data. I have no conflicts of interest with any pharmaceutical companies. These are my opinions regarding Zeposia and other medications based on my personal/clinical experience and review of the literature.
Episode 33: What Do Your Biopsies Mean? The Pathology of Crohn's and Colitis - Shriram Jakate, MD
Dr. Shriram Jakate is Professor Emeritus in pathology at Rush University Medical Center. He has a particular expertise in GI and liver pathology and has been interpreting slides from patients with Crohn's and colitis for over several decades. I consider him to be the best GI pathologist I have encountered in my career and during this podcast we have a wide ranging discussion about interpretation of IBD pathology. We discuss the pathologic features of Crohn's and ulcerative in detail and also go over IBD mimickers (including NSAID induced inflammation), C diff, pouchitis and rethinking the classification of IBD subtypes.
Episode 32: It's Game Time! Management of Fistulizing Crohn's Disease
This is a discussion with Dr. Assad Munis, third year gastroenterology fellow at Advocate Lutheran General Hospital, about his recent presentation "Initial Approach to Fistulizing Crohn's Disease" at our grand rounds.
We discuss pathophysiology, diagnosis, and primarily medical management. We also touch on topics of stem cell therapy, hyperbaric oxygen and exclusive enteral nutrition as potential treatments.
Episode 31: Start Here if you have Crohn's Disease or Ulcerative Colitis!
I made this podcast for those who are newly diagnosed with Crohn's disease or ulcerative colitis.
Dr. K’s Simplified Prescription to Treat IBD
(it’s not that complicated to know what to do)
1.Start with appropriate and optimized medical therapy, preferably by an IBD specialist (like myself).
2.If this works, follow an IBD diet protocol that speaks to you and that you can realistically follow long term. Bottom line is to take out processed food and being plant based is probably helpful.
3.After at least 1 year, if in deep remission (feeling normal, normal colonoscopy, normal biopsies), continue meds if no side effects or consider de-escalation of medical therapy (ie stopping or reducing dose) and continue diet with careful monitoring strategy for recurrence. If there is disease recurrence, restart medical therapy at direction of IBD specialist and consider changing dietary protocol.
4.If you run out of medical therapies or are stuck on prednisone, surgery is a good option which can not only save your life but improve your quality of life.
5.Besides diet and medication, other complementary and alternative therapies (ie supplements, probiotics, etc) are unlikely to be the miracle you hope for.
That is all!
To schedule a phone conversation with me, go to:
https://calendly.com/samir3/against-the-grain
Episode 30: A Deep Dive into the DINE Study: The Specific Carbohydrate Diet vs Mediterranean Diet for Crohn's Disease
This podcast is a deep dive into the recently published article "A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease."
(also known as the Dine Study) published by Lewis, et al.
Article link is here: https://pubmed.ncbi.nlm.nih.gov/34052278/
My guests are Dr. Meghana Doniparthi, gastroenterology fellow at Advocate Lutheran General Hospital and
Kim Beall, Pharm D.
Kim received her Doctor of Pharmacy from the Medical University of South Carolina (MUSC) and her BS in Pharmacy from Auburn University. She has experience in academics and industry, working at MUSC as part of an Internal Medicine team and serving as adjunct faculty at MUSC College of Pharmacy, then working in Health Sciences with Merck as an academic liaison for those publishing and researching in lipids, hypertension, and heart failure. She has been following research in IBD closely since 2013 with her teenage son’s diagnosis of Crohn’s disease, and has become committed to the advancement of nutritional therapy as treatment.
Her website is http://www.ntforibd.org